Blanchette VS, Chen I, de Friedberg ZS, et al. Alloimmunization to the PLA1 platelet antigen: results of a prospective study. Br J Haematol 1990;74:209-15.10.1111/j.1365-2141.1990.tb02567.x
Bussel J, Kaplan C. The fetal and neonatal consequences of maternal alloimmune thrombocytopenia. Baillieres Clin Haematol 1998;11:391-408.10.1016/S0950-3536(98)80057-7
Voak D, Mitchell R, Bowell P, et al. Guidelines for blood grouping and red cell antibody testing during pregnancy. Transfus Med 1996;6:71-4.10.1046/j.1365-3148.1996.d01-518.x
von dem Borne AE, van Leeuwen EF, von Riesz LE, et al. Neonatal alloimmune thrombocytopenia: detection and characterization of the responsible antibodies by the platelet immunoflourescence test. Blood 1981;57:649-56.10.1182/blood.V57.4.649.649
McFarland JG, Frenzke M, Aster RH. Testing of maternal sera in pregnancies at risk for neonatal alloimmune thrombocytopenia. Transfusion 1988; 29:128-33.10.1046/j.1537-2995.1989.29289146830.x2919423
Kaplan C, Daffos F, Forestier F, et al. Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988;72:340-3.10.1182/blood.V72.1.340.340
Bussel JB, Berkowitz RL, McFarland JG, et al. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Eng J Med 1988;319:1374-8.10.1056/NEJM1988112431921033141811
Proulx C, Filion M, Goldman M, et al. Analysis of immunoglobulin class, IgG subclass and titre of HPA-1a antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia. Br J Haematol 1994;87:813-7.10.1111/j.1365-2141.1994.tb06742.x7986721
Panzer S, Auerbach L, Cechova E, et al. Maternal alloimmunization against fetal platelet antigens: a prospective study. Br J Haematol 1995;90:655-60.10.1111/j.1365-2141.1995.tb05597.x
Durand-Zaleski I, Schlegel N, Blum Boisgard C, et al. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comaprison of effectiveness and costs. Am J Perinatol 1996;13:423-31.10.1055/s-2007-994382
Mawas F, Wiener E, Williamson LM, et al. Immunogolobulin G subclass of anti-human platelet antigen 1a in maternal sera: relation to the severity of neonatal alloimmune thrombocytopenia. Br J Haematol 1997;59:287-92.
Williamson LM, Hackett G, Rennie J, et al. The natural history of fetomaternal alloimmunization to the platelet specific antigen HPA-1a (PLA1, Zwa) as determined by antenatal screening. Blood 1998;92:2280-7.10.1182/blood.V92.7.2280
Jaegtvik S, Husebekk A, Aune B, et al. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. BJOG 2000;107:691-4.10.1111/j.1471-0528.2000.tb13315.x
Maslanka K, Guz K, Zupanska B. Antenatal screening of unselected pregnant women for HPA-1a antigen, antibody, and alloimmune thrombocytopenia. Vox Sang 2003;85:326-7.10.1111/j.0042-9007.2003.00363.x
Turner M, Bessos H, Fagge T, et al. Prospective epidemiological study of the outcome and cost effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia (NAIT) due to anti-HPA-1a. Transfusion. In Press.
Bessos H, Goldschmeding R, von dem Borne A, et al. The development of a simple and quick enzyme-linked immunosorbent assay for anti-HPA-1a (PLA1) antibodies. Thromb Res 1993;69:395-400.10.1016/0049-3848(93)90039-Q
Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-6.10.1182/blood.V70.6.1722.1722
Bessos H, Perez S, Armstrong-Fisher S, et al. The development of a quantitative ELISA for antibodies against human platelet antigen type 1a. Transfusion 2003;43:350-6.10.1046/j.1537-2995.2003.00322.x12675721
Bessos H, Hofner M, Salamat A, et al. An international trial demonstrates suitability of a newly developed whole-blood ELISA kit for multicentre platelet HPA-1 phenotyping. Vox Sang 1999;77:103-6.10.1046/j.1423-0410.1999.7720103.x
Sukati H, Bessos H, Barker RN, Urbaniak SJ. Characterization of the alloreactive helper T-cell response to the platelet membrane glycprotein IIIa (integrin beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women. Transfusion 2005;45:1165-77.10.1111/j.1537-2995.2005.00188.x15987363
Kurz M, Stockelle E, Eichelberger B, Panzer S. IgG titer, subclass, and light chain phenotype of pregnancy-induced HPA-5b antibodies that cause or do not cause neonatal alloimmune thrombocytopenia. Transfusion 1999;39:379-82.10.1046/j.1537-2995.1999.39499235669.x10220263
Ohto H, Miura S, Ariga H, et al. The natural history of maternal immunization against fetal platelet alloantigens. Transfus Med 2004;14:399-408.10.1111/j.1365-3148.2004.00535.x15569234
Birchall JE, Murphy MF, Kaplan C, et al. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 2003;122:275-88.10.1046/j.1365-2141.2003.04408.x12846898